
Sinopharm Vaccination Registration Set on July 18
The Chulabhorn Royal Academy invited general people to register for COVID-19 vaccination with the Sinopharm vaccine on July 18.
The Chulabhorn Royal Academy invited general people to register for COVID-19 vaccination with the Sinopharm vaccine on July 18.
Koh Samui, Koh Phangan and Koh Tao islands of Surat Thani province reopened to foreign visitors under the Samui Plus Model project.
Thailand reported on Thursday a daily record of 98 coronavirus deaths and 9,186 new coronavirus cases.
The Government Pharmaceutical Organization (GPO) said it would start to sign contracts for the supplies of the COVID-19 vaccine made by Moderna on July 16.
Thailand is considering limits on exports of locally manufactured AstraZeneca Covid-19 vaccines.
Amid partial business lockdowns in Greater Bangkok, beauty salons and hairdressers’ shops can continue to operate if they stand outside shopping centers and the likes, according to the Center for COVID-19 Situation Administration.
Sixty-nine “COVID-19 Comprehensive Response Teams” will start mass COVID-19 testing in 69 communities of Bangkok tomorrow.
The Government Pharmaceutical Organization filed a defamation complaint against academic Loy Chunpongtong and Dr Boon Vanasin, chairman of Thonburi Healthcare Group PCL, for the allegation that it was making profit from its import of the COVID-19 vaccine made by Moderna.
The Chulabhorn Royal Academy said it did not plan to administer different COVID-19 vaccines for the first and second doses because they were newly developed for emergency use only.
Prime Minister Prayut Chan-o-cha does not oppose the idea of inoculating people against COVID-19 with different kinds of vaccines in series, according to the government spokesman.
The National Communicable Disease Committee ordered medical workers to provide general people with the Sinovac vaccine as the first jab and the AstraZeneca vaccine as the second jab.
The Thai government officially received 1,053,090 doses of the COVID-19 vaccine made by AstraZeneca from the Japanese government.